Actively Recruiting
Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma
Led by Erasmus Medical Center · Updated on 2025-06-11
180
Participants Needed
4
Research Sites
87 weeks
Total Duration
On this page
Sponsors
E
Erasmus Medical Center
Lead Sponsor
B
BeterKeten
Collaborating Sponsor
AI-Summary
What this Trial Is About
A multicentre randomised controlled trial (RCT) will be conducted to evaluate the effectiveness of the digital personalised Melanoma Survivorship Care Plan (SCP) app. A total of hundred-eighty melanoma patients (stage I and II) will be randomised to receive either the SCP Melanoma app or usual care. The app provides survivors with personalized healthcare information on diagnosis, treatment and follow-up and supportive care, tailored to their melanoma stage and phase and information needs.Through questionnaires, medical file records, patient-reported outcomes and use of medical care will be evaluated. In addition, log-data, questionnaires and interviews will be used to evaluate the process of the uptake and implementation of the digital SCP.
CONDITIONS
Official Title
Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older
- Patients diagnosed with primary cutaneous melanoma stage I or II within the past 0 to 4 months
You will not qualify if you...
- Patients with irresectable stage III melanoma
- Patients receiving neo-adjuvant treatment
- Patients with stage IV melanoma
- Patients without sufficient command of the Dutch language
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Albert Schweitzer hospital
Dordrecht, South Holland, Netherlands, 3318 AT
Actively Recruiting
2
Erasmus MC
Rotterdam, South Holland, Netherlands, 3015GD
Actively Recruiting
3
Franciscus Gasthuis & Vlietland hospital
Rotterdam, South Holland, Netherlands, 3045 PM
Not Yet Recruiting
4
Maasstad hospital
Rotterdam, South Holland, Netherlands, 3079 DZ
Actively Recruiting
Research Team
M
Marjolein Lugtenberg, PhD
CONTACT
J
June Kievits, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here